Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Stubenrauch KG"'
Autor:
Lotz GP; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Lutz A; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Martin-Facklam M; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Hansbauer A; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Schick E; Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Moessner E; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Antony M; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Stuchly T; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Viert M; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Hosse RJ; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Freimoser-Grundschober A; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Klein C; Roche Pharma Research and Early Development, Roche Innovation Center Zurich, Schlieren, Switzerland., Schäfer M; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany., Ritter M; Roche Diagnostics GmbH, Antibody Development Technologies, Penzberg, Germany., Stubenrauch KG; Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany.
Publikováno v:
Frontiers in immunology [Front Immunol] 2024 May 31; Vol. 15, pp. 1406353. Date of Electronic Publication: 2024 May 31 (Print Publication: 2024).
Autor:
Sumner G; Regeneron, Tarrytown, NY, USA., Keller S; AbbVie, South San Francisco, CA, USA., Huleatt J; Sanofi Pasteur, Swiftwater, PA, USA., Staack RF; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Wagner L; US FDA, Silver Spring, MD, USA., Azadeh M; Alkermes, Waltham, MA, USA., Bandukwala A; US FDA, Silver Spring, MD, USA., Cao L; Sangamo, Brisbane, CA, USA., Du X; US FDA, Silver Spring, MD, USA., Salinas GF; Janssen, Leiden, South Holland, Netherlands., Garofolo F; BRI Frontage, Vancouver, BC, Canada., Harris S; HilleVax, Cambridge, MA, USA., Hopper S; UK MHRA, London, UK., Irwin C; Health Canada, Ottawa, ON, Canada., Ji Q; AbbVie, North Chicago, IL, USA., Joseph J; Health Canada, Ottawa, ON, Canada., King L; Pfizer, Cambridge, MA, USA., Kinhikar A; Novartis, Cambridge, MA, USA., Lu Y; US FDA, Silver Spring, MD, USA., Luo R; Crinetics, San Diego, CA, USA., Mabrouk O; Biogen, Cambridge, MA, USA., Malvaux L; GSK Vaccines, Rixensart, Belgium., Marshall JC; Moderna, Cambridge, MA, USA., McGuire K; Regeneron, Tarrytown, NY, USA., Mikol V; Sanofi, Vitry-sur-Seine, France., Neely R; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Qiu X; WRIB, Montreal, QC, Canada., Saito Y; Japan MHLW, Tokyo, Japan., Salaun B; GSK Vaccines, Rixensart, Belgium., Scully I; Pfizer, Pearl River, NY, USA., Smeraglia J; UCB, Braine-l'Alleud, Wallonia, Belgium., Solstad T; Norway NoMA, Oslo, Norway., Stoop J; Janssen, Leiden, South Holland, Netherlands., Tang H; GlaxoSmithKline, Collegeville, PA, USA., Teixeira P; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Wang Y; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Wright M; GlaxoSmithKline, Stevenage, UK., Mendez L; Merck, Kenilworth, NJ, USA., Beaver C; Syneos Health, Toronto, ON, Canada., Eacret J; Merck, West Point, PA, USA., Au-Yeung A; Genentech, South San Francisco, CA, USA., Decman V; GlaxoSmithKline, Philadelphia, PA, USA., Dessy F; GSK Vaccines, Rixensart, Belgium., Eck S; AstraZeneca, Gaithersburg, MD, USA., Goihberg P; Pfizer, Andover, MA, USA., Alcaide EG; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Gonneau C; Labcorp, Meyrin, Switzerland., Grugan K; Janssen R&D, Spring House, Pa, USA., Hedrick MN; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Kar S; WRIB, Montreal, QC, Canada., Sehra S; Incyte, Wilmington, DE, USA., Stevens E; Pfizer, Groton, CT, USA., Stevens C; Pfizer, Andover, MA, USA., Sun Y; Bristol-Myers Squibb, Lawrenceville, NJ, USA., McCush F; Pfizer, Groton, CT, USA., Williams L; Bristol-Myers Squibb, Lawrenceville, NJ, USA., Fischer S; Genentech, South San Francisco, CA, USA., Wu B; Janssen R&D, Spring House, Pa, USA., Jordan G; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Burns C; UK MHRA, London, UK., Cludts I; UK MHRA, London, UK., Coble K; Boehringer Ingelheim, Ridgefield, CT, USA., Grimaldi C; Regeneron, Tarrytown, NY, USA., Henderson N; Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Joyce A; Pfizer, Groveland, MA, USA., Lotz G; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Lu Y; Sangamo, Brisbane, CA, USA., Luo L; Merck, West Point, PA, USA., Neff F; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Sperinde G; Genentech, South San Francisco, CA, USA., Stubenrauch KG; Roche Pharma Research & Early Development, Roche Innovation Center, Munich, Germany., Wang Y; WRIB, Montreal, QC, Canada., Ware M; Janssen R&D, Spring House, Pa, USA., Xu W; Merck, West Point, PA, USA.
Publikováno v:
Bioanalysis [Bioanalysis] 2023 Aug; Vol. 15 (15), pp. 861-903. Date of Electronic Publication: 2023 Aug 16.
Autor:
Kavita U; Spark Therapeutics, Inc., Philadelphia, Pennsylvania, 19104, USA. uma.kavita@sparktx.com., Sun K; Takeda Development Center Americas Inc., 125 Binney St, Cambridge, Massachusetts, 02142, USA. kefeng.sun@takeda.com., Braun M; Bayer AG, Pharmaceuticals R&D, 13342, Berlin, Germany., Lembke W; Integrated Biologix GmbH, 4051, Basel, Switzerland., Mody H; Genentech Inc., South San Francisco, California, USA., Kamerud J; Pfizer, Andover, Massachusetts, 01810, USA., Yang TY; Janssen R&D LLC., Spring House, Pennsylvania, 19477, USA., Braun IV; Bayer AG, 42113, Wuppertal, Germany., Fang X; Asklepios BioPharmaceutical, Inc., Research Triangle, North Carolina, 27709, USA., Gao W; EMD Serono Research & Development Institute, Inc., Billerica, Massachusetts, 01821, USA., Gupta S; AbbVie, 2525 Dupont Drive, Irvine, California, 92612, USA., Hofer M; Spark Therapeutics, Inc., Philadelphia, Pennsylvania, 19104, USA., Liao MZ; Genentech Inc., South San Francisco, California, USA., Loo L; Vertex Pharmaceuticals Boston, Boston, Massachusetts, 02210, USA., McBlane F; Novartis, Basel, Switzerland., Menochet K; UCB Pharma Ltd., SL1 3WE, Slough, UK., Stubenrauch KG; Roche Diagnostics GmbH, 82377, Penzberg, Germany., Upreti VV; Amgen, South San Francisco, California, 94080, USA., Vigil A; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, 06877, USA., Wiethoff CM; Eli Lilly and Company, Indianapolis, Indiana, 46285, USA., Xia CQ; ReNAgade Therapeutics, Cambridge, Massachusetts, 02142, USA., Zhu X; AstraZeneca, Waltham, Massachusetts, 02451, USA., Jawa V; Bristol Myers Squibb, Lawrence Township, New Jersey, 08648, USA., Chemuturi N; Takeda Development Center Americas Inc., 125 Binney St, Cambridge, Massachusetts, 02142, USA.
Publikováno v:
The AAPS journal [AAPS J] 2023 Jul 31; Vol. 25 (5), pp. 78. Date of Electronic Publication: 2023 Jul 31.
Autor:
Wessels U; Roche Pharma Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377, Penzberg, Germany. uwe.wessels@roche.com., Zadak M; Roche Pharma Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377, Penzberg, Germany., Weidmann AM; Roche Pharma Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377, Penzberg, Germany., Stuchly T; Roche Pharma Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377, Penzberg, Germany., Stubenrauch KG; Roche Pharma Research & Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377, Penzberg, Germany.
Publikováno v:
The AAPS journal [AAPS J] 2022 Nov 22; Vol. 25 (1), pp. 2. Date of Electronic Publication: 2022 Nov 22.
Autor:
Yang TY; Janssen R&D LLC, Spring House, PA 19477, USA., Braun M; Bayer AG, Pharmaceuticals R&D, Berlin 13342, Germany., Lembke W; UCB Farchim SA, Bulle 1630, Switzerland., McBlane F; Novartis, Basel 4056, Switzerland., Kamerud J; Pfizer BioMedicine Design, Andover, MA 01810, USA., DeWall S; Passage Bio, Philadelphia, PA 19103, USA., Tarcsa E; Abbvie Bioresearch Center, Worcester, MA 01605, USA., Fang X; Asklepios BioPharmaceuticals, Research Triangle Park, NC 27709, USA., Hofer L; Spark Therapeutics Inc, Philadelphia, PA 19104, USA., Kavita U; Spark Therapeutics Inc, Philadelphia, PA 19104, USA., Upreti VV; Amgen Inc, South San Francisco, CA 94080, USA., Gupta S; AbbVie, Irvine, CA 92612, USA., Loo L; Vertex Pharmaceuticals, Boston, MA 02210, USA., Johnson AJ; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877, USA., Chandode RK; AstraZeneca, Gothenburg 43250, Sweden., Stubenrauch KG; Roche Pharma Research and Early Development, Penzberg 82377, Germany., Vinzing M; Bayer AG, Pharmaceuticals R&D, Berlin 13342, Germany., Xia CQ; Takeda Pharmaceuticals International Co, Boston, MA 02139, USA., Jawa V; Bristol Myers Squibb, Lawrence Township, NJ 08648, USA.
Publikováno v:
Molecular therapy. Methods & clinical development [Mol Ther Methods Clin Dev] 2022 Aug 02; Vol. 26, pp. 471-494. Date of Electronic Publication: 2022 Aug 02 (Print Publication: 2022).
Autor:
Pöhler A; Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalysis & Biomarkers, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany., Emrich T; Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalysis & Biomarkers, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany., Jordan G; Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalysis & Biomarkers, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany., Schäfer M; Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalysis & Biomarkers, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany., Stubenrauch KG; Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalysis & Biomarkers, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany., Staack RF; Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalysis & Biomarkers, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany., Zach C; Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalysis & Biomarkers, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany., Meir J; Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalysis & Biomarkers, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany., Faigle J; Roche Pharma Research & Early Development (pRED), Pharmaceutical Sciences, Bioanalysis & Biomarkers, Roche Innovation Center Munich, Roche Diagnostics GmbH, Nonnenwald 2, 82377 Penzberg, Germany.
Publikováno v:
Bioanalysis [Bioanalysis] 2022 Jul; Vol. 14 (13), pp. 923-933. Date of Electronic Publication: 2022 Sep 06.
Autor:
Stock S; Department of Medicine IV, Division of Clinical Pharmacology, University Hospital, Ludwig Maximilian University (LMU), Munich, Germany sophia.stock@med.uni-muenchen.de sebastian.kobold@med.uni-muenchen.de christian.klein.ck1@roche.com.; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU), Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Benmebarek MR; Department of Medicine IV, Division of Clinical Pharmacology, University Hospital, Ludwig Maximilian University (LMU), Munich, Germany.; National Cancer Institute (NCI), Bethesda, Maryland, USA., Kluever AK; Department of Medicine IV, Division of Clinical Pharmacology, University Hospital, Ludwig Maximilian University (LMU), Munich, Germany., Darowski D; Roche Innovation Center Zurich, Roche Pharma Research & Early Development, Schlieren, Switzerland.; Innovent Biologics (Suzhou) Co., Ltd, Suzhou, Jiangsu, China., Jost C; Roche Innovation Center Zurich, Roche Pharma Research & Early Development, Schlieren, Switzerland.; Athebio AG, Schlieren, Switzerland., Stubenrauch KG; Roche Innovation Center Munich, Penzberg, Germany., Benz J; Roche Innovation Center Basel, Basel, Switzerland., Freimoser-Grundschober A; Roche Innovation Center Zurich, Roche Pharma Research & Early Development, Schlieren, Switzerland., Moessner E; Roche Innovation Center Zurich, Roche Pharma Research & Early Development, Schlieren, Switzerland., Umana P; Roche Innovation Center Zurich, Roche Pharma Research & Early Development, Schlieren, Switzerland., Subklewe M; Department of Medicine III, University Hospital, Ludwig Maximilian University (LMU), Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Endres S; Department of Medicine IV, Division of Clinical Pharmacology, University Hospital, Ludwig Maximilian University (LMU), Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany., Klein C; Roche Innovation Center Zurich, Roche Pharma Research & Early Development, Schlieren, Switzerland sophia.stock@med.uni-muenchen.de sebastian.kobold@med.uni-muenchen.de christian.klein.ck1@roche.com., Kobold S; Department of Medicine IV, Division of Clinical Pharmacology, University Hospital, Ludwig Maximilian University (LMU), Munich, Germany sophia.stock@med.uni-muenchen.de sebastian.kobold@med.uni-muenchen.de christian.klein.ck1@roche.com.; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany.; Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jul; Vol. 10 (7).
Autor:
Dickopf S; Large Molecule Research (LMR), Roche Innovation Center Munich, Roche Pharma Research and Early Development (pRED), Penzberg, Germany., Buldun C; Large Molecule Research (LMR), Roche Innovation Center Munich, Roche Pharma Research and Early Development (pRED), Penzberg, Germany., Vasic V; Large Molecule Research (LMR), Roche Innovation Center Munich, Roche Pharma Research and Early Development (pRED), Penzberg, Germany., Georges G; Large Molecule Research (LMR), Roche Innovation Center Munich, Roche Pharma Research and Early Development (pRED), Penzberg, Germany., Hage C; Discovery Oncology, Roche Innovation Center Munich, Roche Pharma Research and Early Development (pRED), Penzberg, Germany., Mayer K; Large Molecule Research (LMR), Roche Innovation Center Munich, Roche Pharma Research and Early Development (pRED), Penzberg, Germany., Forster M; Large Molecule Research (LMR), Roche Innovation Center Munich, Roche Pharma Research and Early Development (pRED), Penzberg, Germany., Wessels U; Pharmaceutical Sciences (PS), Roche Innovation Center Munich, Roche Pharma Research and Early Development (pRED), Penzberg, Germany., Stubenrauch KG; Pharmaceutical Sciences (PS), Roche Innovation Center Munich, Roche Pharma Research and Early Development (pRED), Penzberg, Germany., Benz J; Small Molecule Research, Roche Innovation Center Basel, Roche Pharma Research and Early Development (pRED), Basel, Switzerland., Ehler A; Small Molecule Research, Roche Innovation Center Basel, Roche Pharma Research and Early Development (pRED), Basel, Switzerland., Lauer ME; Chemical Biology, Roche Innovation Center Basel, Roche Pharma Research and Early Development (pRED), Basel, Switzerland., Ringler P; Center for Cellular Imaging and Nano Analytics, Biozentrum University of Basel, Basel, Switzerland., Kobold S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig Maximilians University of Munich, German Center for Lung Research (DZL), Munich, Germany.; German Center for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany., Endres S; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, University Hospital, Ludwig Maximilians University of Munich, German Center for Lung Research (DZL), Munich, Germany.; German Center for Translational Cancer Research (DKTK), Partner Site Munich, Munich, Germany., Klein C; Discovery Oncology, Roche Innovation Center Zurich, Roche Pharma Research and Early Development (pRED), Schlieren, Switzerland., Brinkmann U; Large Molecule Research (LMR), Roche Innovation Center Munich, Roche Pharma Research and Early Development (pRED), Penzberg, Germany.
Publikováno v:
Biological chemistry [Biol Chem] 2022 Jan 20; Vol. 403 (5-6), pp. 495-508. Date of Electronic Publication: 2022 Jan 20 (Print Publication: 2022).
Autor:
Junker F; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Gulati P; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Wessels U; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, F. Hoffmann-La Roche Ltd, Penzberg, Germany., Seeber S; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, F. Hoffmann-La Roche Ltd, Penzberg, Germany., Stubenrauch KG; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, F. Hoffmann-La Roche Ltd, Penzberg, Germany., Codarri-Deak L; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Markert C; Roche Diagnostics GmbH, F. Hoffmann-La Roche Ltd, Penzberg, Germany., Klein C; Roche Pharma Research and Early Development, Discovery Oncology, Roche Innovation Center Zurich, Schlieren, Switzerland., Camillo Teixeira P; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland., Kao H; Roche Pharma Research and Early Development, Early Biomarker Development Oncology, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Publikováno v:
Cytometry. Part A : the journal of the International Society for Analytical Cytology [Cytometry A] 2021 Aug; Vol. 99 (8), pp. 832-843. Date of Electronic Publication: 2021 Mar 18.
Autor:
Bray-French K; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Hartman K; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Steiner G; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Marban-Doran C; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Bessa J; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Campbell N; Global Product Strategy, Pharma Division, F. Hoffmann-La Roche AG, Basel, Switzerland., Martin-Facklam M; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Stubenrauch KG; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Munich, Munich, Germany., Solier C; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Singer T; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland., Ducret A; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, Basel, Switzerland. Electronic address: axel.ducret@roche.com.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2021 Jul; Vol. 110 (7), pp. 2575-2584. Date of Electronic Publication: 2021 Apr 01.